Cargando…
Development and Clinical Trials of Nucleic Acid Medicines for Pancreatic Cancer Treatment
Approximately 30% of pancreatic cancer patients harbor targetable mutations. However, there has been no therapy targeting these molecules clinically. Nucleic acid medicines show high specificity and can target RNAs. Nucleic acid medicine is expected to be the next-generation treatment next to small...
Autores principales: | Yamakawa, Keiko, Nakano-Narusawa, Yuko, Hashimoto, Nozomi, Yokohira, Masanao, Matsuda, Yoko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6747711/ https://www.ncbi.nlm.nih.gov/pubmed/31470511 http://dx.doi.org/10.3390/ijms20174224 |
Ejemplares similares
-
Lung proliferative lesion‐promoting effects of left pulmonary ligation in A/J female mice
por: Yokohira, Masanao, et al.
Publicado: (2020) -
Single Intratracheal Quartz Instillation Induced Chronic Inflammation and Tumourigenesis in Rat Lungs
por: Nakano-Narusawa, Yuko, et al.
Publicado: (2020) -
γH2AX is immunohistochemically detectable until 7 days after exposure of N-bis (2-hydroxypropyl) nitrosamine (DHPN) in rat lung carcinogenesis
por: Ying, Jane Tey Xin, et al.
Publicado: (2018) -
Characteristics of surfactant proteins in tumorigenic and inflammatory lung
lesions in rodents
por: Yokohira, Masanao, et al.
Publicado: (2018) -
Effects of the expectorant drug ambroxol hydrochloride on chemically induced
lung inflammatory and neoplastic lesions in rodents
por: Yoshida, Shota, et al.
Publicado: (2018)